SCHEMBL7012386

SCHEMBL7012386

CNC(=O)c1ccc(/C=C/C(=O)NCc2ccc(Cl)n2-c2ccc(Cl)c(COc3cccc4ccc(C)nc34)c2Cl)cc1

nearest known ligand 0.81

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BDKRB2 P30411 20/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7012385 1.00 BDKRB2 (0.81) BDKRB2
SCHEMBL7014261 0.89 BDKRB2 (1.00) BDKRB2
SCHEMBL7014260 0.89 BDKRB2 (1.00) BDKRB2
Hydrochloric Acid SCHEMBL7015841 0.89 BDKRB2 (1.00) BDKRB2
Hydrochloric Acid SCHEMBL7015842 0.89 BDKRB2 (1.00) BDKRB2
SCHEMBL7012573 0.88 BDKRB2 (0.83) BDKRB2
SCHEMBL7012577 0.88 BDKRB2 (0.83) BDKRB2
SCHEMBL8015043 0.86 BDKRB2 (0.72) BDKRB2
SCHEMBL8015039 0.86 BDKRB2 (0.72) BDKRB2
SCHEMBL7012380 0.85 BDKRB2 (0.64) BDKRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0861243-B1 HETEROCYCLIC COMPOUNDS AS BRADYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO (JP) 2003-11-12 EP disclosed
US-6344462-B1 Heterocyclic compounds as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-02-05 US disclosed
US-6100284-A ANTIALLERGENS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-08-08 US disclosed
US-6008229-A TREATING ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE, SHOCK, PAIN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed